Tsiporah B. Shore

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Francisco M. Marty, Drew J. Winston, Roy F. Chemaly et al. · Biology of Blood and Marrow Transplantation · 2018 · 213 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +16

Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

Celalettin Üstün, Andreas Reiter, Bart L. Scott et al. · Journal of Clinical Oncology · 2014 · 185 citations · Full text

Medicine, Hematology, Immunology +17

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Rubén Niesvizky, David Jayabalan, Paul J. Christos et al. · Blood · 2007 · 183 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Combination Antibody Therapy With Epratuzumab and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma

John P. Leonard, Morton Coleman, Jamie Ketas et al. · Journal of Clinical Oncology · 2005 · 163 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +16